gabitril tiagabine antiseizure medication cephalon forked cool million settle charges marketed several drugs unapproved conditions including provigil gabitril government investigators claimed gabitril marketed treatment anxiety bad considering struck three clinical trials placebo study found evidence gabitril better sugar pill gabitril also allegedly marketed treatment pain i unable locate single controlled study examining efficacy gabitril pain though small number uncontrolled i useful studies suggesting maybe gabitril could used treat pain regarding sleep placebo controlled trials i located suggest drug particularly effective looking drug essentially controlled evidence efficacy pushed pain sleep anxiety well done cephalon supporting evidence label marketing cases came sales rep wore wire collect evidence company marketing practices apparently total four company whistleblowers involved shades peter rost read case philadelphia inquirer ps cephalon published negative anxiety gabitril trials june well established companies often fail publish negative data products cephalon open skeptic might note legal case againt cephalon gaining steam would look even worse cephalon sitting negative data perhaps knowing bad publicity coming due lawsuit led cephalon allow negative anxiety results published could state look open honest i saying possibility reference anxiety trials mark pollack jane tiller fang xie madhukar trivedi tiagabine adult patients generalized anxiety disorder journal clinical psychopharmacology doi jcp bebf update also read related post health care renewal mainly discusses cephalon opiate laced perc pops actiq approved treat cancer pain marketed much broader manner follow mini rant let excuse physicians jumped board docs need much better job checking evidence base though evidence base consists publishing data repeatedly negative trials often published kind evidence base really talking